Development of (68)Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET

[Image: see text] Targeted delivery of diagnostics and therapeutics offers essential advantages over nontargeted systemic delivery. These include the reduction of toxicity, the ability to reach sites beyond biological barriers, and the delivery of higher cargo concentrations to diseased sites. Virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambidis, Elisavet, Chen, Chun-Chieh, Baikoghli, Mo, Imlimthan, Surachet, Khng, You Cheng, Sarparanta, Mirkka, Cheng, R. Holland, Airaksinen, Anu J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346612/
https://www.ncbi.nlm.nih.gov/pubmed/35857429
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346612/
https://www.ncbi.nlm.nih.gov/pubmed/35857429
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00359

Ejemplares similares